Anthem Blue Cross Blue Shield offers several plan types in Arizona including PPO, HMO, and marketplace plans some of which may include coverage for GLP-1 obesity medications when medically indicated
PMID: 23845922
GLP-1 medications offer multiple benefits beyond weight loss: Enhanced insulin sensitivity Reduced inflammation throughout the body Improved blood sugar regulation Slowed gastric emptying, promoting satiety Potential cardiovascular protection Research over the past two years has revealed that GLP-1s are powerful tools for comprehensive metabolic health, not just weight management
A separate ~10,000-patient cardiovascular outcomes trial (TRIUMPH-Outcomes) won't report until 20282029
Glucagon-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice
GLP-1 and GIP-based therapies may be appropriate for individuals with Type 2 diabetes, insulin resistance, or those who are overweight (BMI 2730+) with at least one weight-related condition such as high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease
